Irinotecan for Advanced and Metastatic Breast Cancer
Clinical trial NCT03562390 · UNKNOWN
Trial details
- NCT number
- NCT03562390
- Sponsor
- Liaoning Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-01
- Primary completion
- 2020-01-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.